Viewing Study NCT03908333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:46 AM
Ignite Modification Date: 2026-02-25 @ 6:31 PM
Study NCT ID: NCT03908333
Status: WITHDRAWN
Last Update Posted: 2019-05-30
First Post: 2019-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
Sponsor: Medical College of Wisconsin
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Cancer View
None Pancreatic Cancer View
None Pancreas Cancer View
None Pancreatic Adenocarcinoma Resectable View
None Pancreatic Ductal Adenocarcinoma View
None Pancreatic Metastasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic pancreatic cancer View
None cancer View
None pancreatic View
None Vitamin C View
None Ascorbic Acid View
None Nanoparticle Paclitaxel Protein Bound View
None cisplatin View
None gemcitabine View
None pancreas View